Cancer pharmacogenomics: progress and obstacles toward the goal

Int J Clin Oncol. 2005 Feb;10(1):3-4. doi: 10.1007/s10147-004-0462-9.

Author

Masahiko Nishiyama¹

Affiliation

¹ Department of Translational Cancer Research, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, 734-8551, Japan. yamacho@hiroshima-u.ac.jp

PMID: 15729593
DOI: 10.1007/s10147-004-0462-9

No abstract available

MeSH terms

Humans
International Cooperation
Neoplasms / drug therapy*
Neoplasms / genetics*
Pharmacogenetics / trends*